{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0760","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0760","name":[{"text":"Dose 2 to dose 3 Rotateq interval  28-4 days\nEvaluation_Test_Type: Interval: At Absolute Minimum\nGeneral_Description: This test case describes when dose #3 of a RotaTeq vaccine is administered at 4 weeks  - 4 days from dose #2 that the dose is considered to be valid. The series is complete."}],"gender":"female","birthDate":"2020-03-04"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0760-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"116","display":"ROTATEQ"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"ROTATEQ"}]},"patient":{"reference":"Patient/2013-0760"},"date":"2020-04-30T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0760-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"116","display":"ROTATEQ"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"ROTATEQ"}]},"patient":{"reference":"Patient/2013-0760"},"date":"2020-06-05T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0760-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"116","display":"ROTATEQ"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"ROTATEQ"}]},"patient":{"reference":"Patient/2013-0760"},"date":"2020-06-29T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}